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Complement receptor type 2 (CR2 ; cluster designation-21),' is a 145,000 M,.
glycoprotein that is expressed by mature B lymphocytes (1-4), dendritic cells of
the spleen (5), and pharyngeal epithelial cells (6) . CR2 has specificity for the d
region of the third component of complement, C3, which is most accessible in
the breakdown fragments iC3b and C3dg (7, 8) . CR2 enablesB lymphocytes in
areas distant from sites of inflammation to bind fragments of C3 in conjunction
with immune complexes or bacterial particles.
The role of CR2 in the biology of the B lymphocyte is not well understood,
although thereare reports of growth stimulation ofB lymphocytesthrough CR2.
Certain monoclonal and polyclonal antibodies to CR2 stimulated T cell-depend-
ent proliferation of nontransformed B lymphocytes (9-11), while others did not
(12) . Fragments ofC3 stimulated growth of B lymphoblastoid cell lines in serum-
free medium (13, 14), and human C3d, when crosslinked to Sepharose, main-
tained proliferation of dividing murine B lymphocytes, whereas soluble C3d was
inhibitory (15) . Crosslinking of CR2 and membrane IgM caused a synergistic
increase in the free intracellular calcium concentration in human B lymphocytes
(16) . CR2 has been shown to cocap reciprocally with membrane IgM (17) and to
be phosphorylated after crosslinking of membrane IgM (18, 19), further sug-
gesting a close association of these two proteins in their transmembrane or
cytoplasmic regions .
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PRIMARY STRUCTURE OF HUMAN CR2
CR2 also serves as the receptor for the Epstein-Barr virus (EBV), mediating
virus binding, internalization, and infection ofB lymphocytes (20-24) . The EBV
membrane protein, gp350/220, has recently been identified as the viral protein
that binds to CR2 (17, 25) . CR2 directs the uptake and targeting of EBV to
appropriate vacuoles for removal of the lipid envelope and release of the virus
(26). CR2 also mediates internalization of inert particles coated with the EBV
protein gp350/220 (17), demonstrating that the receptor has endocytic function
when crosslinked with this ligand . The function of CR2 on dendritic cells and
pharyngeal epithelial cells has not been studied . However, as pharyngeal epithe-
lial cells are a site of EBV productive infection, CR2 may mediate viral internal-
ization by this cell type (27) .
Primary sequence analysis of the CR2 protein has demonstrated that it is a
member of a gene family of complement regulatory proteins (28), including
complement receptor type 1 (CR1), C4 binding protein (C4bp), factor H, and
decay-accelerating factor (DAF) (29-35) . CR2 is the only member of the family
that has primary specificity for the d fragment of C3 ; the rest having higher
affinity for Cab and/or Cob . The proteins of the gene family have the common
structural characteristic of comprising 60-75 amino acid repeats with conserved
residues at 11-14 positions . In addition, the genes for these proteins constitute
a linkage group (36) that has been positioned at or near lg32 (37, 38), and four
of these genes, CR1, CR2, DAF, and C4bp, have been physically aligned in this
order within a region of750 kb (39, 40) .
In this paper we report the analysis of the full-length cDNA for human CR2 .
This sequence has been used to identify internally homologous regions within
the CR2 protein and regions of homology with other members of the gene
family . The cDNA has also been used to analyze the organization of the CR2
gene .
Materials and Methods
Cell Culture.
￿
Cells of the B lymphoblastoid line Raji were cultured at 5 X 105/ml to 2
X 106/ml in RPMI 1640 medium containing 10% FCS, 2 mM glutamine, 50 U of
penicillin/ml, and 50 kg of streptomycin/ml in the presence of 10% C02 at 37°C .
Isolation ofCytoplasmic RNA.
￿
Raji cells (1 .5 X 109) were washed in 30 ml of ice-cold
HBSS and suspended in 10 ml of ice-cold buffer containing 0.01 M Tris-HCl (pH 8.0),
0.14 M NaCl, and 1 .5 mM MgC12. 10 ml of this buffer containing 0.8% NP-40 and 20
mM ribonucleoside vanadyl complex (New England Biolabs, Beverly, MA) were added
and the suspension was incubated on ice for 2 min . The nuclei were removed by
centrifugation at 800 g for 5 min at 4°C . The supernatant was made 1% with SDS and 5
mM with EDTA and extracted twice with 65°C phenol and once with chloroform . The
aqueous phase was brought to 0.3 M with sodium acetate and precipitated with 2 .2
volumes of EtOH . The RNA was recovered by centrifugation at 2,500 g for 30 min at
4°C . Total cytoplasmic RNA was poly(A)' selected on oligo-dT-cellulose (41) (Pharmacia
Fine Chemicals, Piscataway, NJ).
Isolation and Sequencing ofCR2cDNAs .
￿
The isolation of X4.11 from a human tonsillar
cDNA library (29) in Xgtl l was previously described (28) . X6.21 and X6.11 were isolated
from the same library by hybridization with probes derived from X4.11 and labeled with
a-[s2P1dCTP by nick translation .
The dideoxy chain termination technique (42) was used for sequencing cDNA that had
been subcloned into M13 vectors by shotgun or directional cloning . DNA synthesis was
polymerized with either Klenow (Boehringer Mannheim Biochemicals, Indianapolis, IN)WEIS ET AL.
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or Sequenase (United States Biochemical Corporation, Cleveland, OH) and dITP was
incorporated in sequences displaying a high degree of GC compaction (43).
Isolation andMappingofOverlapping Genomic Bacteriophage.
￿
A human genomic library
prepared in EMBL3 (44) from DNA purified from normal peripheral blood leukocytes
was screened with probes derived from the CR2 cDNA. Hybriding phage were isolated
and overlapping clones were mapped by restriction endonuclease digestions with Eco RI,
Hind III, and Bam HI (New England BioLabs) (45). The positions of sequences encoding
CR2 protein were identified by hybridization with cDNA probes. Southern blot analysis
of total genomic DNA was also used to confirm the sizes of large (>15 kb) restriction
endonuclease fragments.
Primer Extension Analysis. A 24-nucleotide oligomer (GGAAGGTACCTGAACA-
ACTGTACC)correspondingto nucleotides 143-166of theantisense strand ofthecloned
cDNA was synthesized with a DNA synthesizer (model 380A; Applied Biosystems, Inc.,
Foster City, CA). The fragment was end labeled with T4 polynucleotide kinase and .y-
["P]ATP to a specific activity of 108 cpm/ag. Poly(A)+ selected cytoplasmic RNA (2 ug)
from the B lymphoblastoid line Raji was annealed with 2lAgoflabeledprimer by incubation
in 0.4 M NaCl, 10 mM Pipes (pH 6.4) for 4 min at 85°C and 15 h at 65°C. Reverse
transcription was carried out by adding 80 11 of 10 mM DTT, 6 mM MgC12, 0.5 mM of
each dNTP, 50 mM Tris (pH 8.2), and 25 U of AMV reversetranscriptase (Life Sciences,
Tampa, FL) for 1 h at 41 °C. The reaction volume was increased to 250 JAI with dH20,
extracted with phenol, precipitated with ethanol, and redissolved in 10 JAI of sequencing
dyes. Control M13 DNA that was sequenced and run on the same gel for determination
of the length of extension was subjected to the same buffers and extraction as the primer
extension sample.
Computerized Analysis of DNA and Protein Sequences.
￿
DNA sequence analysis and dot
matrix homology analysis were performedat the computer facility ofthe Howard Hughes
Medical Institute, Harvard Medical School Department of Genetics, using the Genetics
Computer Group software of the University of Wisconsin BiotechnologyCenter (46).
Results
Nucleotide Sequence of Human CR2 cDNA.
￿
Nucleotide sequence analysis was
performed on three overlapping cDNA clones, X6 .21, X4.11, and X6 .11, from a
Xgtll tonsillar library (Fig. IA). The composite cDNA from the clones X6 .21
and X4.11 was 4 kb in length (A). Two internal Eco RI sites were present in the
cDNA, providing three major fragments; a 1.7-kb fragment from the 5' end of
the cDNA, an internal Eco RI fragment of 1.4 kb, and a 0.7-kb fragment from
the 3' end. The full-length internal Eco RI fragment of 1.4 kb present in X4 .11
was found in two other clones in the tonsillar library (not shown). Clone X6 .21
also contained ^-1 kb from the 5' region of this internal Eco RI fragment. In
contrast, the internal Eco RI fragment from clone X6.11 contained ^-200 by of
DNA inserted 283 nucleotides from the 5' end of the fragment, which was not
found in any of the other four clones extending across this region.
The complete nucleotide sequence of the CR2 cDNA is shown in Fig. 1B. The
signal peptide DNA sequence, starting with the initiation codon ATG at position
+1, is underlined, as is the sequence corresponding to the hydrophobic trans-
membrane regions from positions 2,923 to 2,994. The termination codon TGA
at position 3,150 is double underlined. Shown in bold starting at position 3,841
is a poly-adenylation signal sequence. The arrow between nucleotides 1,974 and
1,975 indicatestheposition of theadditional sequence identified in X6.11, leading
to the insertion of 177 nucleotides in the cDNA. The sequence of the additional
DNA in X6.11 is shown in Fig. 1 C.
To confirm that cDNA corresponding to the entire coding region of the5'
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-55 CCCGGACGCTCGCGGGTCTCGGAACGCATCCCGCCGCGGGGGCTTCGGCCGTGGCATGGG 5
6 TTTC 65
66 TTGTGGCTCTCCTCCGCCTATCCTAAATGGCCGGATTAGTTATTATTCTACCCCCATTGC 125
126 TGTTGGTACCGTGATAAGGTACAGTTGTTCAGGTACCTTCCGCCTCATTGGAGAAAAAAG 185
186 TCTATTATGCATAACTAAAGACAAAGTGGATGGAACCTGGGATAAACCTGCTCCTAAATG 245
246 TGAATATTTCAATAAATATTCTTCTTGCCCTGAGCCCATAGTACCAGGAGGATACAAAAT 305
306 TAGAGGCTCTACACCCTACAGACATGGTGATTCTGTGACATTTGCCTGTAAAACCAACTT 365
366 CTCCATGAACGGAAACAAGTCTGTTTGGTGTCAAGCAAATAATATGTGGGGGCCGACACG 425
426 ACTACCAACCTGTGTAAGTGTTTTCCCTCTCGAGTGTCCAGCACTTCCTATGATCCACAA 485
486 TGGACATCACACAAGTGAGAATGTTGGCTCCATTGCTCCAGGATTGTCTGTGACTTACAG 545
546 CTGTGAATCTGGTTACTTGCTTGTTGGAGAAAAGATCATTAACTGTTTGTCTTCGGGAAA 605
606 ATGGAGTGCTGTCCCCCCCACATGTGAAGAGGCACGCTGTAAATCTCTAGGACGATTTCC 665
666 CAATGGGAAGGTAAAGGAGCCTCCAATTCTCCGGGTTGGTGTAACTGCAAACTTTTTCTG 725
726 TGATGAAGGGTATCGACTGCAAGGCCCACCTTCTAGTCGGTGTGTAATTGCTGGACAGGG 785
786 AGTTGCTTGGACCAAAATGCCAGTATGTGAAGAAATTTTTTGCCCATCACCTCCCCCTAT 845
846 TCTCAATGGAAGACATATAGGCAACTCACTAGCAAATGTCTCATATGGAAGCATAGTCAC 905
906 TTACACTTGTGACCCGGACCCAGAGGAAGGAGTGAACTTCATCCTTATTGGAGAGAGCAC 965
966 TCTCCGTTGTACAGTTGATAGTCAGAAGACTGGGACCTGGAGTGGCCCTGCCCCACGCTG 1025
1026 TGAACTTTCTACTTCTGCGGTTCAGTGTCCACATCCCCAGATCCTAAGAGGCCGAATGGT 1085
1086 ATCTGGGCAGAAAGATCGATATACCTATAACGACACTGTGATATTTGCTTGCATGTTTGG 1145
1146 CTTCACCTTGAAGGGCAGCAAGCAAATCCGATGCAATGCCCAAGGCACATGGGAGCCATC 1205
1206 TGCACCAGTCTGTGAAAAGGAATGCCAGGCCCCTCCTAACATCCTCAATGGGCAAAAGGA 1265
1266 AGATAGACACATGGTCCGCTTTGACCCTGGAACATCTATAAAATATAGCTGTAACCCTGG 1325
1326 CTATGTGCTGGTGGGAGAAGAATCCATACAGTGTACCTCTGAGGTGTGGACACCCCCTGT 1385
1386 ACCCCAATGCAAAGTGGCAGCGTGTGAAGCTACAGGAAGGCAACTCTTGACAAAACCCCA 1445
1446 GCACCAATTTGTTAGACCAGATGTCAACTCTTCTTGTGGTGAAGGGTACAAGTTAAGTGG 1505
1506 GAGTGTTTATCAGGAGTGTCAAGGCACAATTCCTTGGTTTATGGAGATTCGTCTTTGTAA 1565WEIS ET AL .
1626 AGAAGATTTTCCATATGGAACCACGGTCACTTACACATGTAACCCTGGGCCAGAAAGAGG
1686 AGTGGAATTCAGCCTCATTGGAGAGAGCACCATCCGTTGTACAAGCAATGATCAAGAAAG
1746 AGGCACCTGGAGTGGCCCTGCTCCCCTGTGTAAACTTTCCCTCCTTGCTGTCCAGTGCTC
1806 ACATGTCCATATTGCAAATGGATACAAGATATCTGGCAAGGAAGCCCCATATTTCTACAA
1866 TGACACTGTGACATTCAAGTGTTATAGTGGATTTACTTTGAAGGGCAGTAGTCAGATTCG
1926 TTGCAAAGCTGATAACACCTGGGATCCTGAAATACCAGTTTGTGAAAAAGAAACATGCCA
1986 GCATGTGAGACAGAGTCTTCAAGAACTTCCAGCTGGTTCACGTGTGGAGCTAGTTAATAC
2046 GTCCTGCCAAGATGGGTACCAGTTGACTGGACATGCTTATCAGATGTGTCAAGATGCTGA
2106 AAATGGAATTTGGTTCAAAAAGATTCCACTTTGTAAAGTTATTCACTGTCACCCTCCACC
2166 AGTGATTGTCAATGGGAAGCACACAGGCATGATGGCAGAAAACTTTCTATATGGAAATGA
2226 AGTCTCTTATGAATGTGACCAAGGATTCTATCTCCTGGGAGAGAAAAAATTGCAGTGCAG
2286 AAGTGATTCTAAAGGACATGGATCTTGGAGCGGGCCTTCCCCACAGTGCTTACGATCTCC
2346 TCCTGTGACTCGCTGCCCTAATCCAGAAGTCAAACATGGGTACAAGCTCAATAAAACACA
2406 TTCTGCATATTCCCACAATGACATAGTGTATGTTGACTGCAATCCTGGCTTCATCATGAA
2466 TGGTAGTCGCGTGATTAGGTGTCATACTGATAACACATGGGTGCCAGGTGTGCCAACTTG
2526 TATCAAAAAAGCCTTCATAGGGTGTCCACCTCCGCCTAAGACCCCTAACGGGAACCATAC
2586 TGGTGGAAACATAGCTCGATTTTCTCCTGGAATGTCAATCCTGTACAGCTGTGACCAAGG
2646 CTACCTGCTGGTGGGAGAGGCACTCCTTCTTTGCACACATGAGGGAACCTGGAGCCAACC
2706 TGCCCCTCATTGTAAAGAGGTAAACTGTAGCTCACCAGCAGATATGGATGGAATCCAGAA
2766 AGGGCTGGAACCAAGGAAAATGTATCAGTATGGAGCTGTTGTAACTCTGGAGTGTGAAGA
2826 TGGGTATATGCTGGAAGGCAGTCCCCAGAGCCAGTGCCAATCGGATCACCAATGGAACCC
2886 TCCCCTGGCGGTTTGCAGATCCCGTTCACTTGCTCCT,
2946
3006 ACGCAATTATTATACAGATACAAGCCAGAAAGAAGCTTTTCATTTAGAAGCACGAGAAGT
3066 ATATTCTGTTGATCCATACAACCCAGCCAGCTGATCAGAAGACAAACTGGTGTGTGCCTC
3126 ATTGCTTGGAATTCAGCGGAATATlfa&TTAGAAAGAAACTGCTCTAATATCAGCAAGTCT
3186 CTTTATATGGCCTCAAGATCAATGAAATGATGTCATAAGCGATCACTTCCTATATGCACT
3246 TATTCTCAAGAAGAACATCTTTATGGTAAAGATGGGAGCCCAGTTTCACTGCCATATACT
3306 CTTCAAGGACTTTCTGAAGCCTCACTTATGAGATGCCTGAAGCCAGGCCATGGCTATAAA
3366 CAATTACATGGCTCTAAAAAGTTTTGCCCTTTTTAAGGAAGGCACTAAAAAGAGCTGTCC
3426 TGGTATCTAGACCCATCTTCTTTTTGAAATCAGCATACTCAATGTTACTATCTGCTTTTG
3486 GTTATAATGTGTTTTTAATTATCTAAAGTATGAAGCATTTTCTGGGGTTATGATGGCCTT
3546 ACCTTTATTAGGAAGTATGGTTTTATTTTGATAGTAGCTTCCTCCTCTGGTTGGTGTTAA
3606 TCATTTCATTTTTACCCTTACTTGGTTTGAGTTTCTCTACATTACTGTATATACTTTGCC
3666 TTTCCATAATCACTCAGTGATTGCAATTTGCACAAGTTTTTTTAAATTATGGGAATCAAG
3726 ATTTAATCCTAGAGATTTGGTGTACAATTCAGGCTTTGGATGTTTCTTTAGCAGTTTTGT
3786 GATAAGTTCTAGTTGCTTGTAAAATTTCACTTAATAATGTGTACATTAGTCATTCAATAA
3846 ATTGTAATTGTAAAGAAAACAAA 3868
FIGURE 1 .
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B (continued) . See legend under Fig. 1C.
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C
1975 GGCTGCCAGCCACCTCCTGGGCTCCACCATGGTCATCATACAGGTGGAAATACGGTCTTC 2034
2035 TTTGTCTCTGGGATGACTGTAGACTACACTTGTGACCCTGGCTATTTGCTTGTGGGAAAC 2094
2095 AAATCCATTCACTGTATGCCTTCAGGAAATTGGAGTCCTTCTGCCCCACGGTGTGAA 2151
FIGURE 1 .
￿
Nucleotide sequence of the human CR2cDNA. Nucleotide sequence analysis was
performed on three overlapping cDNA clones isolated from a human tonsillar cDNA library
in Xgt11 . The composite cDNA is represented by the top line of A, with the positions of the
following restriction endonuclease sites indicated: SSp I (S), Pst I (P), Bbv I (B), Eco RI (R),
and Xba I(X). The placement of the overlappingcDNA clones is indicated below. The insert
above X6.11, labeled 10X, indicates the position of the additional sequence present in this
clonebutnot in X4.1 1 or X6.21 . The position and direction oftheM13 subclones which were
sequenced are indicatedby the arrows in the lower portion ofA. The nucleotide sequence of
the human CR2 cDNA is shown in B . The sequences corresponding to the predicted signal
peptide (+1-60) and the transmembrane region (2,923-2,994) are underlined. The position
of the termination codon (3,150) is double underlined and the recognition sequence for
polyadenylation (3,841) is in bold . The arrowbetween positions 1,974and 1,975 indicates the
site of insertion of the additional 177 nucleotides in X6.11 . Ccontains the nucleotide sequence
of this region of X6.11 . These sequence data have been submitted to EMBL/Gen Bank
Librariesunderthe accession number Y00649 .
FIGURE 2 .
￿
Primer extension analysis of CR2 mRNA . A 24-nu-
cleotide oligomer derivedfrom the positions 143-166 of the anti-
sense strand of the cDNA was end labeled with y-[' sP]ATP and
used to prime reverse transcription ofpoly(A)+ selected cytoplasmic
RNA from Raji cells . Indicatedon the right of the autoradiograph
are the positions of migration of ssDNA as determined from a
controlM13 sequence . The arrowon the left indicates the position
of the primer extension fragment .A
C
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VDPYNPAS
ITKDKVDGTWDKPAPI~
ANNMWGPTRLPT
SSGKWSAVPPT
V
WEPTW$ AQGT V
AQGTWEPSAP~V
SEVWTPPVPQ
GTIPWFMEIRL
SNDQER
NTWDPEIPV
DAENGIWFKKIPL
SDSKGHGSWSGPSPC
DNTWVPGVPT
HEGTWSQPAPH
SDHQWNPPLAV
10a 659 GCQPPPGLHHGHHTGGNTVFFVSGMTVDYT CDPGYLLVGIJKSIH
￿
CMPSGIJWSPSAPR CE
I(10-13)F-.Q-I/V-F/Y-.--GF/Y---.GE/S----jC(3-7 )
FIGURE 3.
￿
Derived amino acid sequence of human CR2. The amino acid sequence derived
from the nucleotide sequence of theCR2 cDNA is shownin A. Residues 1-20 correspond to
thepredicted signal peptide. Residues 21-974 contain 15 copies ofthe SCR sequences. These
repeats are aligned by the positions of the four cysteine residues, which are boxed. Shown in
italics are the positions of 11 sites for N-linked glycosylation. The five underlined sequences
correspond to the amino acid sequences ofCR2 tryptic peptides. Residues 975-998 comprise
the transmembrane region and residues 999-1032 the cytoplasmic region. Indicated in bold
in the transmembrane andcytoplasmic region are those residues that could serve as substrates
for phosphorylation. The amino acid sequence derived from the additional 177 nucleotides of
clone X6.11 are shownin B, with the positions of two sites for N-linked glycosylation double
underlined. The positions of 23 residues which are conserved in over half the CR2 repeats
are shown in C. Residues common to other proteins having the SCR are underlined.
mRNA had been cloned, primer extension analysis was performed. A 24-
nucleotide oligomer derived from positions 143-166 of the antisense strand of
the cDNA was end labeled and used to prime reverse transcription ofpoly(A)'
selected cytoplasmic RNA from the B lymphoblastoid line Raji. A single-labeled
DNA fragment of236 nucleotides in length was synthesized (Fig. 2), indicating
that the site of initiation of transcription of CR2 message was 15 nucleotides
upstream from the cDNA. Primer extension analysis with RNA from the B
lymphoblastoid cell line SB indicated the same site was used for initiation of
transcription in this cell line, while no DNA fragments were synthesized with
RNA from a CR2- T cell line HSB-2 (data not shown).
Primary StructureofHuman CR2.
￿
The derived amino acidsequence ofhuman
CR2 is shown in Fig. 3A. A hydrophobic signal peptide of^-20 amino acids was
identified in the NH2-terminal portion of the protein. Application of the von
Heijne rules (47) places the cleavage site for the mature peptide at position 20,
SCR AA
1 MGAAGLLGVFLALVAPGVLG
1 21 IS SPPPILNGRISYYSTPIAVGTVIRYS GTFRLIGEKSLL
2 88 YSS EPIVPGGYKIRGSTPYRHGDSVTFA Tj_jFSMNGI_{KSVW
3 152 LE ALPMIHNGHHTSENVGSIAPGLSVTYS SGYLLVGEKIIN
4 215 _ SLGRFPNGKVKEPPILRVGVTANFF EGYRLQGPPSSR
5 274 IF SPPPILNGRHIGNSLAIIVSYGSIVTYT PDPEEGVNFILIGESTL
6 348 AVQ HPQILRGRMVSGQKDRYTYIIDTVIFA GFTLKGSKQIR
7 409 E APPNILNGQKEDRHMVRFDPGTSIKYS PGYVLVGEESIQ
8 467 V ATGRQLLTKPQHQFVRPDVIISS EGYKLSGSVYQE
9 524 IT PPPVIYNGAHTGSSLEDFPYGTTVTYT PGPERGVEFSLIGESTI
10 598 AVQ HVHIANGYKISGKEAPYFYKDTVTFK YSGFTLKGSSQIR
11 659 ET HVRQSLOFLPACSRVELVNTS
2)
DGYQLTGHAYQM
12 716 IH PPPVIVNGKHTGMMAENFLYGNEVSYE QGFYLLGEKKLQ
13 784 VTR NPEVKHGYKLIIKTHSAYSHNDIVYVD PGFIMIIGSRVIR
14 848 IG PPPKTPNGIIHTGGNIARFSPGMSILYS QGYLLVGEALLL
15 909 SPADMDGIQKGLEPRKMYQYGAVVTLE DGYMLEGSPQSQ
975 VLCGIAAGLILLTFLIVVTLYVIS KHRARNYYTDTSQKEAFHLEAREVY
H1054
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FIGURE 4 .
￿
Hydrophilicity analysis of the
CR2 peptide . Hopp-Woods hydrophilicity
analysis was performed on the derived
amino acid sequence ofCR2using theDNA
Inspector II+ software (Textco, W . Leba-
non, NH) on an AppleMacintosh Plus com-
puter. The regions corresponding to the
signal peptide and transmembrane region
are labeled aand b, respectively.
between the glycineand isoleucine residues . However, theNH2 terminus of CR2
is blocked(48) andthe exact site of cleavage is not known. Immediatelyfollowing
the signal peptide are 15 copies, in tandem, of the short consensus repeat (SCR)
sequence found in other members of the family of C3/C4 bp . The underlined
sequences (Fig. 3A) correspond to sequences of tryptic peptides determined for
the CR2 protein (28) . The SCRs comprise 954 residues of the CR2 peptide .
Immediately following the final SCR is a 24-amino acid hydrophobic sequence
that may represent the transmembrane region and a 34-amino acid putative
cytoplasmic domain . The assignment of the signal peptide at nucleotide +1 of
the cDNA, nucleotide 70 of the mRNA, was supported by the hydrophilicity
analysis of the CR2 peptide sequence (Fig . 4) . Two regions of extended hydro-
phobicity were identified, one corresponding to the signal peptide at the NH2-
terminal portion of the protein, and the other to the transmembrane region
towards the COOH terminus . Thus, the entire extracellular portion of CR2
probably comprises SCRs, making CR2 resemble CR1 but not DAF in this
respect, the latter having a serine-threonine-rich region that is O-glycosylated
(33, 34) . Within the cytoplasmic region, four tyrosines, two threonines, and four
serines were identified that could serve as substrates for phosphorylation (49) .
Two of the serines, at positions 998 and 1,010, are located close to basic residues
and may be substrates for phosphorylation by protein kinase C (50) .
Indicated in Fig . 3B is the amino acid sequence derived from the additional
DNA found in the internal Eco RI fragment of clone X6 .11 . This corresponds
exactly to the insertion ofan SCR between the 10th and 11th SCRs identified
in four other cDNA clones and is labeled SCR-10X . The fact that the reading
frame is maintained in X6.1 I and that the positions of residues common to other
SCRs are conserved argues that this cDNA clone reflects an alternative splicing
event or the transcriptional product from a different allele rather than a cloning
artifact or an unspliced intervening sequence . In addition, this region is not
flanked by consensus splice sequences . SCR-1Oamay correspond to the additional
SCR reported by Moore et al . (51) .
The SCRs of this gene family are characterized by the four conserved cysteines
which are aligned and indicated by boxes in Fig. 3A . Shown in Fig. 3C are the
positions of 23 residues conserved in over half of the CR2 repeats . The under-WEIS ET AL.
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lined glycine, tryptophan, and prolines are also characteristic of the SCR struc-
ture of other C3/C4 binding proteins.
The positions of 11 potential sites of N-linked glycosylation, Asn-X-Ser/Thr,
are double underlined in Fig. 3A. Two additional sites are present in SCR-10a
shown in B. These findings are consistentwith the 8-11 N-linked oligosaccharides
previously predicted for CR2 from comparison of the estimated molecular weight
of the high mannose-containing precursor and the nonglycosylated forms of CR2
(52). The molecular weight of the peptide encoded by the open reading frame
is 112,716, which is also similar to the molecular weight of 111,000 determined
for the nonglycosylated form of CR2 . The predicted signal peptide has a
molecular weight of 2,162 and SCR 10-a from X6.11 has a molecular weight of
6,234.
Analysis of Internal Homologies in CR2.
￿
Dot matrix homology analysis was
performed on the entire derived amino acid sequence of CR2, with and without
SCR-10X, to determine whether groups of SCRs formed repeating homologous
sequences (Fig. 5). A pattern is evident, beginning at the NH2 terminus, wherein
the sequence contained in SCR-1 through -4 is tandemly repeated three times
within CR2, with similar SCRs occupying the same relative positions within each
group. That is, SCRs -l, -5, -9, and -12 are similar, as are SCRs -2, -6, -10, and
-13, SCRs -3, -7, and -14, and SCRS -4, -8, and -11 . The C001-1-terminal SCR-
15 does not conform to this pattern, most resembling SCRs -6, -10, and -13
rather than SCRs-4,-8, and -11 . Thus, in the absence of SCR-10X, the additional
sequence found in clone X6.11, the first and second group contain four SCRs,
and the third and fourth contain three SCRs (Fig. 5). Interestingly, SCR-10a is
located between SCR-10 and -11 and is most homologous to SCR-3, -7, and -14,
so that its presence completes the third group of linked SCRs (Fig. 5). Therefore,
the 15 or 16 SCRs of CR2 are organized into four homologous groups of linked
repeats. The actual breakpoints between groups cannot be determined and there
is an alternative grouping of SCRs which is consistent with this organization in
which group I would consist of SCRs 1-3, group II of SCRs 4-7, group III of
SCRs 8-10X, and group IV of SCRs 11-14. SCRs -4 and -8 are both homologous
to SCR-11 but display little homology with other SCRs, indicating they contain
relatively unique sequences which could have functional importance.
Comparison of CR2 to Other Members of the Gene Family.
￿
An earlier study
demonstrated that tryptic peptides of human CR2 were homologous with the
amino acid sequence derived from human CRI cDNA and that CR2 cDNA
crosshybridized with CRI cDNA under conditions of low stringency hybridiza-
tion (28). To determine the extent of the relatedness between the two proteins,
dot matrix homology analysis was performed between the derived amino acid
sequence of CR2 and the derived amino acid sequence of CRI (30) (Fig. 6A).
The CRI sequence contains three long homologous repeats that are 70-99%
identical and that comprise seven SCRs. The CRI sequence also includes the
transmembrane and the cytoplasmic regions. In addition to multiple short regions
of homology between CR2 and each long homologous repeat of CR1, there were
four extended regions that tended to correspond to the four linked groups of
SCRs in CR2. In addition, the linked group of short consensus repeats found in
CR2 was partially duplicated in each long repeat ofCR1 suggesting that the long1056
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of the final SCR, the transmembrane region, and
the cytoplasmic region of CR2 is aligned with the
corresponding regions from CR1 (30). Identical
residues are indicated by the vertical lines between
the two sequences. The residues which are under-
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homologous repeat of CR1 may have been generated by duplication of a
primordial group of three to four SCRs. Less homology was detected between
the N1-12-terminal SCR of each CR1 long homologous repeat and the CR2
sequence, suggesting that a CR1 function not shared by CR2 may reside in this
region. Similarly, SCR-8 of CR2 may be involved in a function unique to this
receptor, as it demonstrated little homology with any SCRs ofCR1.
There was an extended homology between SCR-14 and -15 of CR2 and the
two most COOH-terminal SCRs ofCR1 (Fig. 6). The final two SCRs ofCR1 are
distinguished by their not being included within long homologous repeats (30)
and, as noted earlier, SCR-15 of CR2 is not part of one of the groups of linked
SCRs. The amino acid sequences of the final short consensus repeat, the trans-
membrane region, and the cytoplasmic region for both CR2 and CR1 are
compared in Fig. 7. 64% ofthe residues in the final short consensus repeat were
identical between the two proteins, with other conservative substitutions. The
identity dropped to 25% in the transmembrane region. The cytoplasmic regions
of both proteins began with the putative anchor sequence, Lys-His-Arg, and
contained 12 conserved residues, with the CR1 sequence extending 9 residues
further. These similarities between CR2 and CR1 in the sequence and spacing
of the final short consensus repeat, the transmembrane region, and the cyto-
plasmic region provide evidence for derivation from a common membrane-
bound precursor gene.
Comparison ofthe amino acid sequence of CR2 with the derived amino acid
sequence of C4bp (31) (Fig. 6B) also revealed regions of homology, although
much less than that observed between CR2 and CR1. The homology pattern
was similar to that observed between CR2 and CR1 as the NH2-terminal SCR of
C4bp showed little homology with that of CR2, again suggesting that this SCR
may be related to functions shared by CR1 and C4bp but not CR2, such as the
binding ofCab and C4b. Comparison with the derived amino acid sequence of
DAF (33) (Fig. 6C) revealed homology between CR2 and the carboxyl half ofWEIS ET AL.
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the SCR-containing region of DAF, less in the NH2-terminal SCRs of DAF, and
none with the serine-threonine carboxyl tail of DAF. At the level of stringency
used in this analysis, little homology was detected between CR2 and the partial
sequence of factor H (32) (Fig. 6D). Thus, factor H may have diverged earlier
from the presumptive ancestral gene encoding the other C3/C4 binding proteins.
Genomic Organization ofHuman CR2.
￿
Four EMBL3 bacteriophage containing
overlapping human genomic DNA were isolated by hybridization to cDNA
probes derived from CR2 cDNA and a map encompassing 43 kb of DNA was
generated from restriction endonuclease sites (Fig. 8). The location of sequences
hybridizing to probes derived from coding and noncoding sequences in the
cDNA was determined (Fig. 8A). A single Eco RI to Bam HI fragment of 0 .9 kb
was identified that hybridized to 2-7, a 0.7-kb probe containing only 3' untrans-
lated sequence (Fig. 8B). Several fragments interspaced on 12.5 kb of DNA
hybridized to 2-14, a 1 .4-kb probe derived from the 3' region of the coding
sequence and containing six copies of the SCR sequence, the transmembrane
region, and the cytoplasmic region. The cDNA probe 2-16, a 1 .6-kb fragment
from the 5' region of the coding sequence but lacking the 165 nucleotides
corresponding to the most 5' region of the mRNA, hybridized to fragments in
6.5 kb of genomic DNA. 2-18, which contains 317 by from the most 5' region
of the cloned cDNA and, therefore lacked only 15 nucleotides from the 5' end
of the mRNA, hybridized to a single 1 .4-kb Hind III to Eco RI fragment. The
24-nucleotide oligomer derived from nucleotides 143-166 of the cDNA also
hybridized only to this 1 .4-kb fragment. Thus, the exons encoding the translated
CR2 sequence are contained within 25 kb of genomic DNA.
Discussion
Human CR2 is a member of the family of complement regulatory proteins
including CR1, C4bp, DAF, and factor H (35). In addition to their functional
relatedness, these proteins comprise tandem copies of a 60-75-amino acid SCR
(29-33). The positions of four cysteines, a tryptophan, several glycines, and
several prolines, are conserved within each copy of this repeat. It has been
determined from analysis of proteolytic fragments of N2-glycoprotein I, a protein
not involved in complement but comprising SCRs, that the first and third
cysteines and the second and fourth cysteines of each repeat are disulfide linked
(53). The proline residues are clustered in close proximity to the first and fourth
cysteines in these proteins. This suggests that in proteins containing this repeat
rigid SCRs are interspaced with angular hinges, which is consistent with the
observation of flexible rodlike structures in electron micrographs of C4bp (54).
Members of this family are related genetically as CR1, C4bp, and H have been
chromosomally linked by family studies of protein polymorphisms (36), CR2 and
CR1 have been mapped by in situ hybridization to band lg32 (37), and all five
have been placed on chromosome 1 by human-mouse hybrid mapping panels
(35, 37, 38).
Although clearly a member of this family, CR2 has functionally diverged from
the other members in that it has primary specificity for the d region of C3, it
cannot accelerate the decay of classical or alternative pathway convertases, and
its cofactor activity is restricted to particle bound iC3b (48, 55). It is unique also1060
￿
PRIMARY STRUCTURE OF HUMAN CR2
A
5'
B
H
2-24
O
2-16
H
I
R
I
R
I
0.4 kb
5.0 kb
FIGURE 8.
￿
Genomicorganization of humanCR2. The placementof five cDNA probes used
for isolation and mapping of the genomic bacteriophage is diagramed in A. 2-7 is a 0.7-kb
fragment from the 3' end ofthecDNA that contained only 3' untranslated sequence. 2-14 is
a 1.4-kb Eco RI to Eco RI fragment from the middle of the cDNA that encodessix copies of
the SCR, the transmembrane, and the cytoplasmic regions. 2-16 is a 1.6-kb fragment from
the 5' end ofthecDNA, lacking 165 nucleotides from the most 5' region ofthe mRNA, and
encoding only SCR sequences. 2-18 is a317-bp fragment starting 15 nucleotides downstream
of the initiation codon for transcription and containing 5' untranslated sequence, the signal
peptide and 202 by encoding short consensus repeat sequence. 2-24 if the 24-nucleotide
oligomer derivedfrom positions 143-166of the cDNA. Themapoftheoverlapping genomic
phage is shown in B. The position ofthe followingrestriction endonuclease sitesare shown on
the composite chromosome bar in the top of B: Bam HI (B), Hind III (H), and Eco RI (R).
The positions of the individual overlapping phage are drawn below the bar. Hybridization to
the cDNA probes is indicated by placement of the circles and boxes below the chromosome 1
bar.
3'
in its ability to bind the EBV glycoprotein gp350j220 and in being the only
member of the family that is found primarily on the B lymphocyte.
Analysis of the derived amino acid sequence of CR2 has provided information
pertaining to its own evolution and that of other members of the gene family.
The extracellular portion of CR2 comprises four groups of linked SCRs, with
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groups I and II containing four SCRs and groups III and IV containing three
SCRs (Fig. 5). This structural organization suggests that SCR may have arisen
by duplication of a primordial gene segment containing exons encoding four
short consensus repeats. The identification of the fourth SCR of group III, SCR-
I Oa, in X6.11 supports the concept of linked groups of four SCRs. The functional
significance of four groups of linked SCRs is not clear as it is not known whether
CR2 is multivalent with respect to binding of C3d. The ligand binding site may
be located within the NH2-terminal group, with the others serving primarily to
extend the receptor from the plasma membrane, as has been suggested for the
long homologous repeats of CRI (30). The C4 binding site of C4bp has also
been localized to the periphery of each of the seven C4bp rods that make up the
C4bp complex (54). As the entire extracellular portion of CR2 comprises SCRs,
the ligand binding sites for C3d and EBV must be formed by this basic structural
element.
Evidence for polymorphism of CR2 has been presented in this paper. A single
cDNA clone that was isolated from the human tonsillar library contained a 177-
nucleotide long insert ^-2 kb from the 5' end that encoded a single SCR (Figs. 1
and 4) that probably corresponds to that recently found by Moore et al. (51).
Four other clones did not contain this DNA sequence. This cDNA may represent
the product of a different allele or an alternative splicing event from the same
precursor RNA . As the insert maintains reading frame, encodes an SCR, and is
not flanked by consensus splice sequences, it is likely to be an in vivo transcrip-
tional product and not an unspliced intervening sequence or an artifact of cDNA
cloning. Furthermore, short exposure of autoradiographs from Northern blot
analysis of mRNA from tonsils and B lymphoblastoid cells does allow discrimi-
nation of two distinct, but closely migrating mRNA species of 4 .8 kb (data not
shown). Although there is no evidence for polymorphism in CR2 at the protein
level, mature CR2 migrates as a diffuse band because it contains complex
oligosaccharides that alter the migration by 35,000 mol wt (52) and could
potentially mask the difference of6,000 mol wt between the two predicted forms.
Comparison of the sequence of CR2 with the sequence of CRI demonstrated
a high degree of relatedness between the two proteins and suggested that the
long homologous repeats of CRI could have arisen by duplication of the same
primordial group of linked SCRs that have been duplicated to generate CR2.
The homology between the two proteins was also evident in their 000H-
terminal regions (Figs. 6 and 7). This similarity in the sequence and spacing of
the final SCR, the transmembrane region, and the cytoplasmic region of CR2
and CRI suggests that this entire portion of the CR2 and CRI genes may have
originated from an ancestral gene encoding a membrane-bound, SCR-containing
peptide. However, divergence has also occurred in the cytoplasmic regions of
CR2 and CRI, most notably being the presence of four tyrosine residues in CR2
that are not found in CRI . Consistent with these structural differences being the
basis for differing functions of these receptors on B cells is the phosphorylation
of CR2 but not CRI during treatment of cells with phorbol esters and the
stimulation of B cells that has been observed after crosslinking of CR2 but not
CRI . The availability of full-length cDNA for CR2 now makes possible a1062
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molecular analysis of its B cell-activating function induced by binding of the
C3d and EBV ligands.
Summary
Human complement receptor type 2 (CR2) is the B lymphocyte receptor for
C3d and the Epstein-Barr virus. This protein is also a member of a family of
Cab/C4b binding proteins that regulate complement activation, comprise tan-
demly repeated 60-75 amino acid sequences, and whose genes map to band q32
on chromosome 1 . Overlapping cDNA clones encoding the entire human CR2
protein have been isolated from a human tonsillar cDNA library. The derived
amino acid sequence of 1,032 residues encodes a peptide of 112,716 mol wt. A
signal peptide was identified, followed by 15 copies of the short consensus repeat
(SCR) structure common to the C3/C4 binding protein family. The entire
extracellular portion of the protein comprised SCRs, thus, the ligand binding
sites both for C3d and the EBV protein gp350/220 are positioned within this
structure. Immediately following the final SCR was a transmembrane sequence
of 24 amino acidsand a cytoplasmic region of 34 amino acids. One of five cDNA
clones isolated contained an additional SCR, providing evidence for alternative
mRNA splicing or gene products of different human alleles. The CR2 cDNAs
were used to isolate CR2-specific genomic phage. The entire CR2 coding
sequences were found within 20 kb of human DNA. Analysis of the CR2 cDNA
sequence indicated that CR2 contained internally homologous regions and
suggested that CR2 arose by duplication of a primordial gene sequence encoding
four SCRs. Comparison of the CR2 peptide sequence with those of other
members of the gene family has identified many regions highly homologous with
human CR1, fewer with C4bp and decay accelerating factor, and very few with
factor H, and suggested that CR2 and CR1 arose by duplication of the same
ancestral gene sequence. The homology between CR2 and CR1 extended to the
transmembrane and cytoplasmic regions, suggesting that these sequences were
derived from a common membrane-bound precursor.
We acknowledge the excellent technical assistance of Sarah R. Burrow.
Receivedfor publication 18 November 1987.
Note added in proof . The termination codon is at nucleotides 3097-3099 rather than at nucleotides
3150-3152. The sequence of CR2 deduced from a cDNA clone isolated from a Raji lymphoblastoid
cell library has recently been published (57). A major difference in the sequence of SCR 12 (SCR 13
in Moore et al. [57]) is present which may reflect differences in the cellular origin of the mRNA used
to prepare the cDNA libraries.
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